SB
Shankar Bhagwanrao Jadhav
About Shankar Bhagwanrao Jadhav
Data last updated:
Shankar Bhagwanrao Jadhav is a Director at Relevium Pharma Private Limited (since 2024). The companies operate in Trading and Education & Learing. Relevium Pharma Private Limited reported revenue of ₹81.3 Lakh (FY 2025). Earlier, Shankar Bhagwanrao Jadhav was a Director at Radhesham Edusocial Foundation (2020–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Mar 2024 | 2016 | ₹81.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Oct 2020 | 2020 | ₹2.5 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shankar Bhagwanrao Jadhav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dnyaneshwar Gambhir Patil | 07530938 | Relevium Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankar Bhagwanrao Jadhav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankar Bhagwanrao Jadhav
Shankar Bhagwanrao Jadhav currently holds 1 directorship: Relevium Pharma Private Limited (Director, since 15 Mar 2024, revenue ₹81.3 Lakh (FY 2025)).
Shankar Bhagwanrao Jadhav was first appointed on 29 Oct 2020 as Director at Radhesham Edusocial Foundation. The most recent appointment on record is 15 Mar 2024 at Relevium Pharma Private Limited.
Shankar Bhagwanrao Jadhav held 1 earlier board appointment: Radhesham Edusocial Foundation (Director, 29 Oct 2020 to 25 Jan 2025).
The current boards of Shankar Bhagwanrao Jadhav's companies include Dnyaneshwar Gambhir Patil (Relevium Pharma Private Limited).